From Nasdaq.: 2025-04-01 14:38:00

Shares of Johnson & Johnson (NYSE: JNJ) dropped 6.3% while the S&P 500 and Nasdaq were down. A judge rejected a $10 billion talc settlement, leading J&J to fight cases individually. The company denies its products cause cancer, despite allegations. The Motley Fool Stock Advisor team did not include J&J in their top 10 stock picks. Consider joining Stock Advisor for potential high returns. Johnny Rice has no position in the mentioned stocks. The Motley Fool recommends Johnson & Johnson. The author’s opinions do not necessarily reflect Nasdaq, Inc.



Read more at Nasdaq.: Why Johnson & Johnson Stock Is Sinking Today